New search | Conferencedetail
mail
Print view
 
 

3rd RAS/MAPK Pathway Targeted Drug Discovery Summit

Evvnt Promotion / evvnt
-
22.02.2022 - 24.02.2022  Online, USA
Time: 9:00 AM - 3:30 PM
 
Conference themes
For decades, RAS proteins have been considered “undruggable.” This all changed following the recent approval of the first-ever targeted KRAS G12C therapy, marking a major landmark for this community. This breakthrough has certainly laid out a roadmap for future success, with more investment and innovation in the field than ever before, particularly within emerging discovery strategies being pursued by the biopharma industry.
Professional congress organizer (PCO)
Hanson Wade
 

Enquiries and Registration:

https://go.evvnt.com/913421-2?pid=4832
Ms. Georgina FitzGerald
 
Categories
General Medicine
Languages
English
Congress fees
USD 1899.00 - USD 3796.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Swiss Tropical and Public Health InstituteHilfswerk AustriaOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichische Gesellschaft für Public HealthÄrztekammer für WienCharité International AcademyÖsterreichisches Rotes Kreuz